Fibromyalgia: nosography and therapeutic perspectives
Stefano Coaccioli1, Giustino Varrassi, Chiara Sabatini
1Department of Internal Medicine and Rheumatology Unit, Perugia University School of Medicine, Terni, Italy. scoaccioli@tin.it
Summary
Fibromyalgia (FM) is a chronic pain condition potentially caused by inherited neuro-vegetative imbalances. Treatment emphasizes non-pharmacological approaches and multimodal medication management.
Area of Science:
- Neuroscience
- Immunology
- Endocrinology
Background:
- Fibromyalgia (FM) significantly impacts patient morbidity and healthcare costs.
- Key symptoms include widespread chronic pain and disrupted sleep.
- The exact cause of FM remains incompletely understood.
Purpose of the Study:
- To propose a theoretical framework for the pathogenesis of Fibromyalgia.
- To explore the role of neuro-vegetative systems and serotoninergic pathways in FM.
- To highlight therapeutic strategies for managing Fibromyalgia.
Main Methods:
- Theoretical model development based on existing research.
- Review of neurological, immunological, and endocrine mechanisms.
- Synthesis of evidence regarding serotoninergic neurotransmission.
Main Results:
- A theory suggests FM arises from inherited neuro-vegetative imbalance due to serotoninergic deficiency.
- Increased sympathetic tone may be a consequence of this metabolic issue.
- Precipitating events can trigger clinical manifestations in susceptible individuals.
Conclusions:
- The proposed theory integrates genetic predisposition and environmental factors.
- Dysfunction in the serotoninergic system is a key area of focus.
- Effective Fibromyalgia management requires integrated non-pharmacological and pharmacological interventions.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:44Nociception
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...